Colorectal Cancer Screening: Shield and the ECLIPSE Study

William M. Grady, MD, of Fred Hutchinson Cancer Center, shares an overview of the ECLIPSE study and its significance in colorectal cancer screening, including the key findings that led to the FDA approval of the Shield test.

Dr. Grady also explains in detail how the Shield test differs from existing colorectal cancer screening methods, such as colonoscopy and stool-based tests.

View his continued comments on Determining the Optimal Colorectal Cancer Screening Option for Patients.

—

0:20-1:49 Overview of the ECLIPSE study and the Shield test

1:58-3:00 Screening tests available for colorectal cancer

3:00-5:23 Sensitivity and specificity comparisons of all screening options

5:25-7:28 How to decide which screening test to use

7:30-10:05 Balancing convenience with accessibility and accuracy when picking a test